Multidisciplinary Progress in Obesity Research
Abstract
:1. Epidemiology and the Financial Burden of Obesity
2. Characteristic of Obesity
3. Obesity as a Risk Factor for Other Diseases
4. Obesity and Cancer
5. Obesity-Associated Diabetes and Neurological Diseases
6. Multidisciplinary Treatment of Obesity
7. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Di Cesare, M.; Bentham, J.; Stevens, G.A.; Zhou, B.; Danaei, G.; Lu, Y.; Bixby, H.; Cowan, M.J.; Riley, L.M.; Hajifathalian, K.; et al. Trends in adult body-mass index in 200 countries from 1975 to 2014: A pooled analysis of 1698 population-based measurement studies with 19.2 million participants. Lancet 2016, 387, 1377–1396. [Google Scholar]
- Ataey, A.; Jafarvand, E.; Adham, D.; Moradi-Asl, E. The relationship between obesity, overweight, and the human development index in world health organization eastern mediterranean region countries. J. Prev. Med. Public Health 2020, 53, 98–105. [Google Scholar] [CrossRef] [PubMed]
- Lin, X.; Li, H. Obesity: Epidemiology, pathophysiology, and therapeutics. Front. Endocrinol. 2021, 12, 706978. [Google Scholar] [CrossRef] [PubMed]
- WHO. World Health Organization (WHO): Obesity and Overweight; WHO: Geneva, Switzerland, 2020. [Google Scholar]
- Pan, X.F.; Wang, L.; Pan, A. Epidemiology and determinants of obesity in china. Lancet Diabetes Endocrinol. 2021, 9, 373–392. [Google Scholar] [CrossRef]
- Singh, G.M.; Danaei, G.; Farzadfar, F.; Stevens, G.A.; Woodward, M.; Wormser, D.; Kaptoge, S.; Whitlock, G.; Qiao, Q.; Lewington, S. The age-specific quantitative effects of metabolic risk factors on cardiovascular diseases and diabetes: A pooled analysis. PLoS ONE 2013, 8, e65174. [Google Scholar] [CrossRef] [PubMed]
- Swinburn, B.A.; Sacks, G.; Hall, K.D.; McPherson, K.; Finegood, D.T.; Moodie, M.L.; Gortmaker, S.L. The global obesity pandemic: Shaped by global drivers and local environments. Lancet 2011, 378, 804–814. [Google Scholar] [CrossRef]
- Lauby-Secretan, B.; Scoccianti, C.; Loomis, D.; Grosse, Y.; Bianchini, F.; Straif, K. Body fatness and cancer—Viewpoint of the iarc working group. N. Engl. J. Med. 2016, 375, 794–798. [Google Scholar] [CrossRef]
- Afshin, A.; Forouzanfar, M.H.; Reitsma, M.B.; Sur, P.; Estep, K.; Lee, A.; Marczak, L.; Mokdad, A.H.; Moradi-Lakeh, M.; Naghavi, M.; et al. Health effects of overweight and obesity in 195 countries over 25 years. N. Engl. J. Med. 2017, 377, 13–27. [Google Scholar]
- Ng, M.; Fleming, T.; Robinson, M.; Thomson, B.; Graetz, N.; Margono, C.; Mullany, E.C.; Biryukov, S.; Abbafati, C.; Abera, S.F.; et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: A systematic analysis for the global burden of disease study 2013. Lancet 2014, 384, 766–781. [Google Scholar] [CrossRef]
- Siegel, R.L.; Jemal, A.; Wender, R.C.; Gansler, T.; Ma, J.; Brawley, O.W. An assessment of progress in cancer control. CA A Cancer J. Clin. 2018, 68, 329–339. [Google Scholar] [CrossRef]
- Wang, Y.C.; McPherson, K.; Marsh, T.; Gortmaker, S.L.; Brown, M. Health and economic burden of the projected obesity trends in the USA and the uk. Lancet 2011, 378, 815–825. [Google Scholar] [CrossRef]
- Waters, H.; DeVol, R. Weighing down America: The Health and Economic Impact of Obesity; Milken Institute Center for Public Health: Washington, DC, USA, 2021. [Google Scholar]
- Pop-Busui, R.; Boulton, A.J.; Feldman, E.L.; Bril, V.; Freeman, R.; Malik, R.A.; Sosenko, J.M.; Ziegler, D. Diabetic neuropathy: A position statement by the american diabetes association. Diabetes Care 2017, 40, 136–154. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Narbro, K.; Agren, G.; Jonsson, E.; Näslund, I.; Sjöström, L.; Peltonen, M. Pharmaceutical costs in obese individuals: Comparison with a randomly selected population sample and long-term changes after conventional and surgical treatment: The sos intervention study. Arch. Intern. Med. 2002, 162, 2061–2069. [Google Scholar] [CrossRef]
- Dobbs, R.; Sawers, C.; Thompson, F.; Manyika, J.; Woetzel, J.R.; Child, P.; McKenna, S.; Spatharou, A. Overcoming Obesity: An Initial Economic Analysis; McKinsey Global Institute: New York, NY, USA, 2014. [Google Scholar]
- World Health Organization. Obesity and Overweight. Fact Sheet No. 311. January 2015; Volume 13. Available online: http://www.who.int/mediacentre/factsheets/fs311/en/Stand (accessed on 2 June 2015).
- Yuan, F.; Zhang, Q.; Dong, H.; Xiang, X.; Zhang, W.; Zhang, Y.; Li, Y. Effects of des-acyl ghrelin on insulin sensitivity and macrophage polarization in adipose tissue. J. Transl. Int. Med. 2021, 9, 84–97. [Google Scholar] [CrossRef] [PubMed]
- Ladabaum, U.; Mannalithara, A.; Myer, P.A.; Singh, G. Obesity, abdominal obesity, physical activity, and caloric intake in us adults: 1988 to 2010. Am. J. Med. 2014, 127, 717–727.e2. [Google Scholar] [CrossRef] [PubMed]
- McTigue, K.; Larson, J.C.; Valoski, A.; Burke, G.; Kotchen, J.; Lewis, C.E.; Stefanick, M.L.; Van Horn, L.; Kuller, L. Mortality and cardiac and vascular outcomes in extremely obese women. JAMA 2006, 296, 79–86. [Google Scholar] [CrossRef]
- Khanna, D.; Khanna, S.; Khanna, P.; Kahar, P.; Patel, B.M. Obesity: A chronic low-grade inflammation and its markers. Cureus 2022, 14, e22711. [Google Scholar] [CrossRef]
- Deng, T.; Lyon, C.J.; Bergin, S.; Caligiuri, M.A.; Hsueh, W.A. Obesity, inflammation, and cancer. Annu. Rev. Pathol. 2016, 11, 421–449. [Google Scholar] [CrossRef]
- Hanahan, D.; Coussens, L.M. Accessories to the crime: Functions of cells recruited to the tumor microenvironment. Cancer Cell 2012, 21, 309–322. [Google Scholar] [CrossRef]
- Rueda-Clausen, C.F.; Ogunleye, A.A.; Sharma, A.M. Health benefits of long-term weight-loss maintenance. Annu. Rev. Nutr. 2015, 35, 475–516. [Google Scholar] [CrossRef]
- Lu, Y.; Hajifathalian, K.; Ezzati, M.; Woodward, M.; Rimm, E.B.; Danaei, G.; Selmer, R.; Strand, B.H.; Dobson, A.; Hozawa, A.; et al. Metabolic mediators of the effects of body-mass index, overweight, and obesity on coronary heart disease and stroke: A pooled analysis of 97 prospective cohorts with 1·8 million participants. Lancet 2014, 383, 970–983. [Google Scholar] [PubMed]
- Renehan, A.G.; Tyson, M.; Egger, M.; Heller, R.F.; Zwahlen, M. Body-mass index and incidence of cancer: A systematic review and meta-analysis of prospective observational studies. Lancet 2008, 371, 569–578. [Google Scholar] [CrossRef]
- Aras, M.; Tchang, B.G.; Pape, J. Obesity and diabetes. Nurs. Clin. N. Am. 2021, 56, 527–541. [Google Scholar] [CrossRef] [PubMed]
- Kleinert, M.; Clemmensen, C.; Hofmann, S.M.; Moore, M.C.; Renner, S.; Woods, S.C.; Huypens, P.; Beckers, J.; De Angelis, M.H.; Schürmann, A. Animal models of obesity and diabetes mellitus. Nat. Rev. Endocrinol. 2018, 14, 140–162. [Google Scholar] [CrossRef]
- Poirier, P.; Giles, T.D.; Bray, G.A.; Hong, Y.; Stern, J.S.; Pi-Sunyer, F.X.; Eckel, R.H. Obesity and cardiovascular disease: Pathophysiology, evaluation, and effect of weight loss. Arterioscler. Thromb. Vasc. Biol. 2006, 26, 968–976. [Google Scholar] [CrossRef]
- Pivtorak, K.V.; Shevchuk, N.A.; Pivtorak, N.A.; Fedzhaga, I.V. Correction of adipocyte secretion disorders in patients with non-alcoholic fatty liver disease with overweight and obesity. Wiad. Lek. (Wars. Pol. 1960) 2019, 72, 1477–1480. [Google Scholar] [CrossRef]
- Serradilla Martín, M.; Oliver Guillén, J.R.; Palomares Cano, A.; Ramia Ángel, J.M. Metabolic syndrome, non-alcoholic fatty liver disease and hepatocarcinoma. Rev. Esp. Enferm. Dig. Organo Of. Soc. Esp. Patol. Dig. 2020, 112, 133–138. [Google Scholar] [CrossRef]
- Zorena, K.; Jachimowicz-Duda, O.; Ślęzak, D.; Robakowska, M.; Mrugacz, M. Adipokines and obesity. Potential link to metabolic disorders and chronic complications. Int. J. Mol. Sci. 2020, 21, 3570. [Google Scholar] [CrossRef]
- Tchang, B.G.; Saunders, K.H.; Igel, L.I. Best practices in the management of overweight and obesity. Med. Clin. N. Am. 2021, 105, 149–174. [Google Scholar] [CrossRef]
- Wormser, D.; Kaptoge, S.; Di Angelantonio, E.; Wood, A.M.; Pennells, L.; Thompson, A.; Sarwar, N.; Kizer, J.R.; Lawlor, D.A.; Nordestgaard, B.G.; et al. Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: Collaborative analysis of 58 prospective studies. Lancet 2011, 377, 1085–1095. [Google Scholar]
- Hatem, S.N. Atrial Fibrillation and Obesity: Not Just a Coincidence; American College of Cardiology Foundation: Washington, DC, USA, 2015; Volume 66, pp. 12–13. [Google Scholar]
- Ren, J.; Wu, N.N.; Wang, S.; Sowers, J.R.; Zhang, Y. Obesity cardiomyopathy: Evidence, mechanisms, and therapeutic implications. Physiol. Rev. 2021, 101, 1745–1807. [Google Scholar] [CrossRef] [PubMed]
- Steele, C.B.; Thomas, C.C.; Henley, S.J.; Massetti, G.M.; Galuska, D.A.; Agurs-Collins, T.; Puckett, M.; Richardson, L.C. Vital signs: Trends in incidence of cancers associated with overweight and obesity—United states, 2005–2014. MMWR Morb. Mortal. Wkly. Rep. 2017, 66, 1052–1058. [Google Scholar] [CrossRef] [PubMed]
- Gallagher, E.J.; LeRoith, D. Obesity and diabetes: The increased risk of cancer and cancer-related mortality. Physiol. Rev. 2015, 95, 727–748. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Scappaticcio, L.; Maiorino, M.I.; Bellastella, G.; Giugliano, D.; Esposito, K. Insights into the relationships between diabetes, prediabetes, and cancer. Endocrine 2017, 56, 231–239. [Google Scholar] [CrossRef]
- Aune, D.; Norat, T.; Vatten, L.J. Body mass index, abdominal fatness and the risk of gallbladder disease. Eur. J. Epidemiol. 2015, 30, 1009–1019. [Google Scholar] [CrossRef]
- Brewer, C.J.; Balen, A.H. The adverse effects of obesity on conception and implantation. Reproduction 2010, 140, 347–364. [Google Scholar] [CrossRef]
- Bellastella, G.; Menafra, D.; Puliani, G.; Colao, A.; Savastano, S. How much does obesity affect the male reproductive function? Int. J. Obes. Suppl. 2019, 9, 50–64. [Google Scholar] [CrossRef]
- Gregoriou, O.; Bakas, P.; Grigoriadis, C.; Creatsa, M.; Hassiakos, D.; Creatsas, G. Changes in hormonal profile and seminal parameters with use of aromatase inhibitors in management of infertile men with low testosterone to estradiol ratios. Fertil. Steril. 2012, 98, 48–51. [Google Scholar] [CrossRef]
- Practice Committee of the American Society for Reproductive Medicine. Obesity and reproduction: A committee opinion. Fertil. Steril. 2021, 116, 1266–1285. [Google Scholar] [CrossRef]
- Flint, S.W.; Čadek, M.; Codreanu, S.C.; Ivić, V.; Zomer, C.; Gomoiu, A. Obesity discrimination in the recruitment process: “You’re not hired!”. Front. Psychol. 2016, 7, 647. [Google Scholar] [CrossRef]
- Dixon, J.B.; Dixon, M.E.; O’Brien, P.E. Depression in association with severe obesity: Changes with weight loss. Arch. Intern. Med. 2003, 163, 2058–2065. [Google Scholar] [CrossRef] [PubMed]
- Dalamaga, M.; Christodoulatos, G.S.; Mantzoros, C.S. The role of extracellular and intracellular nicotinamide phosphoribosyl-transferase in cancer: Diagnostic and therapeutic perspectives and challenges. Metabolism 2018, 82, 72–87. [Google Scholar] [CrossRef] [PubMed]
- Kim, D.S.; Scherer, P.E. Obesity, diabetes, and increased cancer progression. Diabetes Metab. J. 2021, 45, 799–812. [Google Scholar] [CrossRef]
- Khandekar, M.J.; Cohen, P.; Spiegelman, B.M. Molecular mechanisms of cancer development in obesity. Nat. Rev. Cancer 2011, 11, 886–895. [Google Scholar] [CrossRef] [PubMed]
- WCRF/AICR. Continuous Update Project Expert Report 2018. Body Fatness and Weight Gain and the Risk of Cancer; World Cancer Research Fund/American Institute for Cancer Research: London, UK, 2018; ISBN 978-1-912259-26-7. [Google Scholar]
- Jarvis, D.; Mitchell, J.S.; Law, P.J.; Palin, K.; Tuupanen, S.; Gylfe, A.; Hänninen, U.A.; Cajuso, T.; Tanskanen, T.; Kondelin, J.; et al. Mendelian randomisation analysis strongly implicates adiposity with risk of developing colorectal cancer. Br. J. Cancer 2016, 115, 266–272. [Google Scholar] [CrossRef]
- Aune, D.; Navarro Rosenblatt, D.A.; Chan, D.S.M.; Vingeliene, S.; Abar, L.; Vieira, A.R.; Greenwood, D.C.; Bandera, E.V.; Norat, T. Anthropometric factors and endometrial cancer risk: A systematic review and dose-response meta-analysis of prospective studies. Ann. Oncol. Off. J. Eur. Soc. Med. Oncol. 2015, 26, 1635–1648. [Google Scholar] [CrossRef]
- Staiano, A.E.; Reeder, B.A.; Elliott, S.; Joffres, M.R.; Pahwa, P.; Kirkland, S.A.; Paradis, G.; Katzmarzyk, P.T. Body mass index versus waist circumference as predictors of mortality in canadian adults. Int. J. Obes. 2012, 36, 1450–1454. [Google Scholar] [CrossRef]
- Staunstrup, L.M.; Nielsen, H.B.; Pedersen, B.K.; Karsdal, M.; Blair, J.P.M.; Christensen, J.F.; Bager, C.L. Cancer risk in relation to body fat distribution, evaluated by dxa-scans, in postmenopausal women—The prospective epidemiological risk factor (perf) study. Sci. Rep. 2019, 9, 5379. [Google Scholar] [CrossRef]
- Chen, J.; Du, B. Novel positioning from obesity to cancer: Fto, an m6a rna demethylase, regulates tumour progression. J. Cancer Res. Clin. Oncol. 2019, 145, 19–29. [Google Scholar] [CrossRef]
- Deng, X.; Su, R.; Stanford, S.; Chen, J. Critical enzymatic functions of fto in obesity and cancer. Front. Endocrinol. 2018, 9, 396. [Google Scholar] [CrossRef]
- Hernández-Caballero, M.E.; Sierra-Ramírez, J.A. Single nucleotide polymorphisms of the fto gene and cancer risk: An overview. Mol. Biol. Rep. 2015, 42, 699–704. [Google Scholar] [CrossRef] [PubMed]
- Loos, R.J.F.; Yeo, G.S.H. The bigger picture of fto—the first gwas-identified obesity gene. Nat. Rev. Endocrinol. 2014, 10, 51–61. [Google Scholar] [CrossRef] [PubMed]
- Mehrdad, M.; Doaei, S.; Gholamalizadeh, M.; Fardaei, M.; Fararouei, M.; Eftekhari, M.H. Association of fto rs9939609 polymorphism with serum leptin, insulin, adiponectin, and lipid profile in overweight adults. Adipocyte 2020, 9, 51–56. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Barone, I.; Giordano, C.; Bonofiglio, D.; Andò, S.; Catalano, S. The weight of obesity in breast cancer progression and metastasis: Clinical and molecular perspectives. Semin. Cancer Biol. 2020, 60, 274–284. [Google Scholar] [CrossRef] [PubMed]
- Mauro, L.; Naimo, G.D.; Gelsomino, L.; Malivindi, R.; Bruno, L.; Pellegrino, M.; Tarallo, R.; Memoli, D.; Weisz, A.; Panno, M.L.; et al. Uncoupling effects of estrogen receptor α on lkb1/ampk interaction upon adiponectin exposure in breast cancer. FASEB J. 2018, 32, 4343–4355. [Google Scholar] [CrossRef]
- Booth, A.; Magnuson, A.; Fouts, J.; Foster, M. Adipose tissue, obesity and adipokines: Role in cancer promotion. Horm. Mol. Biol. Clin. Investig. 2015, 21, 57–74. [Google Scholar] [CrossRef]
- Scherer, P.E. The multifaceted roles of adipose tissue—therapeutic targets for diabetes and beyond: The 2015 banting lecture. Diabetes 2016, 65, 1452–1461. [Google Scholar] [CrossRef]
- Di Zazzo, E.; Polito, R.; Bartollino, S.; Nigro, E.; Porcile, C.; Bianco, A.; Daniele, A.; Moncharmont, B. Adiponectin as link factor between adipose tissue and cancer. Int. J. Mol. Sci. 2019, 20, 839. [Google Scholar] [CrossRef]
- Brochu-Gaudreau, K.; Rehfeldt, C.; Blouin, R.; Bordignon, V.; Murphy, B.D.; Palin, M.-F. Adiponectin action from head to toe. Endocrine 2010, 37, 11–32. [Google Scholar] [CrossRef]
- Wang, G.X.; Zhao, X.Y.; Lin, J.D. The brown fat secretome: Metabolic functions beyond thermogenesis. Trends Endocrinol. Metab. 2015, 26, 231–237. [Google Scholar] [CrossRef]
- Pischon, T.; Nimptsch, K. Obesity and Risk of Cancer: An Introductory Overview; Springer: Cham, Switzerland, 2016; pp. 1–15. [Google Scholar]
- Chen, X.; Wang, Y. Adiponectin and breast cancer. Med. Oncol. 2011, 47, 33–43. [Google Scholar] [CrossRef] [PubMed]
- Fu, S.; Xu, H.; Liu, C.; Gu, M.; Wang, Q.; Zhou, J.; Wang, Z. [role of adiponectin in prostate cancer: A preliminary study]. Zhonghua Nan Ke Xue = Natl. J. Androl. 2017, 23, 975–981. [Google Scholar]
- Gao, Q.; Zheng, J.; Yao, X.; Peng, B. Adiponectin inhibits vegf-a in prostate cancer cells. Tumour Biol. J. Int. Soc. Oncodev. Biol. Med. 2015, 36, 4287–4292. [Google Scholar] [CrossRef] [PubMed]
- Shrestha, A.; Nepal, S.; Kim, M.J.; Chang, J.H.; Kim, S.-H.; Jeong, G.-S.; Jeong, C.-H.; Park, G.H.; Jung, S.; Lim, J.; et al. Critical role of ampk/foxo3a axis in globular adiponectin-induced cell cycle arrest and apoptosis in cancer cells. J. Cell. Physiol. 2016, 231, 357–369. [Google Scholar] [CrossRef]
- Xing, S.Q.; Zhang, C.G.; Yuan, J.F.; Yang, H.M.; Zhao, S.D.; Zhang, H. Adiponectin induces apoptosis in hepatocellular carcinoma through differential modulation of thioredoxin proteins. Biochem. Pharmacol. 2015, 93, 221–231. [Google Scholar] [CrossRef]
- Moon, H.-S.; Liu, X.; Nagel, J.M.; Chamberland, J.P.; Diakopoulos, K.N.; Brinkoetter, M.T.; Hatziapostolou, M.; Wu, Y.; Robson, S.C.; Iliopoulos, D.; et al. Salutary effects of adiponectin on colon cancer: In vivo and in vitro studies in mice. Gut 2013, 62, 561–570. [Google Scholar] [CrossRef] [PubMed]
- Otani, K.; Ishihara, S.; Yamaguchi, H.; Murono, K.; Yasuda, K.; Nishikawa, T.; Tanaka, T.; Kiyomatsu, T.; Hata, K.; Kawai, K.; et al. Adiponectin and colorectal cancer. Surg. Today 2017, 47, 151–158. [Google Scholar] [CrossRef]
- Saxena, A.; Baliga, M.S.; Ponemone, V.; Kaur, K.; Larsen, B.; Fletcher, E.; Greene, J.; Fayad, R. Mucus and adiponectin deficiency: Role in chronic inflammation-induced colon cancer. Int. J. Colorectal Dis. 2013, 28, 1267–1279. [Google Scholar] [CrossRef]
- Saxena, A.; Chumanevich, A.; Fletcher, E.; Larsen, B.; Lattwein, K.; Kaur, K.; Fayad, R. Adiponectin deficiency: Role in chronic inflammation induced colon cancer. Biochim. Biophys. Acta Mol. Basis Dis. 2012, 1822, 527–536. [Google Scholar] [CrossRef]
- Kim, A.Y.; Lee, Y.S.; Kim, K.H.; Lee, J.H.; Lee, H.K.; Jang, S.H.; Kim, S.E.; Lee, G.Y.; Lee, J.W.; Jung, S.A.; et al. Adiponectin represses colon cancer cell proliferation via adipor1- and -r2-mediated ampk activation. Mol. Endocrinol. 2010, 24, 1441–1452. [Google Scholar] [CrossRef]
- Guo, X.; Liu, J.; You, L.; Li, G.; Huang, Y.; Li, Y. Association between adiponectin polymorphisms and the risk of colorectal cancer. Genet. Test. Mol. Biomark. 2015, 9, 9–13. [Google Scholar] [CrossRef] [PubMed]
- Taliaferro-Smith, L.; Nagalingam, A.; Knight, B.B.; Oberlick, E.; Saxena, N.K.; Sharma, D. Integral role of ptp1b in adiponectin-mediated inhibition of oncogenic actions of leptin in breast carcinogenesis. Neoplasia 2013, 15, 23-IN11. [Google Scholar] [CrossRef] [PubMed]
- Wu, X.; Yan, Q.; Zhang, Z.; Du, G.; Wan, X. Acrp30 inhibits leptin-induced metastasis by downregulating the jak/stat3 pathway via ampk activation in aggressive spec-2 endometrial cancer cells. Oncol. Rep. 2012, 27, 1488–1496. [Google Scholar] [PubMed]
- Man, K.; Ng, K.T.P.; Xu, A.; Cheng, Q.; Lo, C.M.; Xiao, J.W.; Sun, B.S.; Lim, Z.X.H.; Cheung, J.S.; Wu, E.X.; et al. Suppression of liver tumor growth and metastasis by adiponectin in nude mice through inhibition of tumor angiogenesis and downregulation of rho kinase/ifn-inducible protein 10/matrix metalloproteinase 9 signaling. Clin. Cancer Res. 2010, 16, 967–977. [Google Scholar] [CrossRef] [Green Version]
- Cui, E.; Guo, H.; Shen, M.; Yu, H.; Gu, D.; Mao, W.; Wang, X. Adiponectin inhibits migration and invasion by reversing epithelial-mesenchymal transition in non-small cell lung carcinoma. Oncol. Rep. 2018, 40, 1330–1338. [Google Scholar] [CrossRef]
- Kahn, C.R.; Wang, G.; Lee, K.Y. Altered adipose tissue and adipocyte function in the pathogenesis of metabolic syndrome. J. Clin. Investig. 2019, 129, 3990–4000. [Google Scholar] [CrossRef]
- Orgel, E.; Mittelman, S.D. The links between insulin resistance, diabetes, and cancer. Curr. Diabetes Rep. 2013, 13, 213–222. [Google Scholar] [CrossRef]
- Wang, M.; Zhao, J.; Zhang, L.; Wei, F.; Lian, Y.; Wu, Y.; Gong, Z.; Zhang, S.; Zhou, J.; Cao, K.; et al. Role of tumor microenvironment in tumorigenesis. J. Cancer 2017, 8, 761–773. [Google Scholar] [CrossRef]
- Ouchi, N.; Parker, J.L.; Lugus, J.J.; Walsh, K. Adipokines in inflammation and metabolic disease. Nat. Rev. Immunol. 2011, 11, 85–97. [Google Scholar] [CrossRef]
- Park, J.; Euhus, D.M.; Scherer, P.E. Paracrine and endocrine effects of adipose tissue on cancer development and progression. Endocr. Rev. 2011, 32, 550–570. [Google Scholar] [CrossRef]
- Kumar, S.; Behl, T.; Sachdeva, M.; Sehgal, A.; Kumari, S.; Kumar, A.; Kaur, G.; Yadav, H.N.; Bungau, S. Implicating the effect of ketogenic diet as a preventive measure to obesity and diabetes mellitus. Life Sci. 2021, 264, 118661. [Google Scholar] [CrossRef] [PubMed]
- Kazamel, M.; Stino, A.M.; Smith, A.G. Metabolic syndrome and peripheral neuropathy. Muscle Nerve 2021, 63, 285–293. [Google Scholar] [CrossRef] [PubMed]
- Hicks, C.W.; Selvin, E. Epidemiology of peripheral neuropathy and lower extremity disease in diabetes. Curr. Diabetes Rep. 2019, 19, 86. [Google Scholar] [CrossRef] [PubMed]
- Feldman, E.L.; Nave, K.A.; Jensen, T.S.; Bennett, D.L.H. New horizons in diabetic neuropathy: Mechanisms, bioenergetics, and pain. Neuron 2017, 93, 1296–1313. [Google Scholar] [CrossRef] [Green Version]
- Gonçalves, N.P.; Vægter, C.B.; Pallesen, L.T. Peripheral glial cells in the development of diabetic neuropathy. Front. Neurol. 2018, 9, 268. [Google Scholar] [CrossRef]
- Feldman, E.L.; Callaghan, B.C.; Pop-Busui, R.; Zochodne, D.W.; Wright, D.E.; Bennett, D.L.; Bril, V.; Russell, J.W.; Viswanathan, V. Diabetic neuropathy. Nat. Rev. Dis. Primers 2019, 5, 41. [Google Scholar] [CrossRef]
- Bodman, M.A.; Varacallo, M. Peripheral diabetic neuropathy. In Statpearls; StatPearls Publishing: Tampa, FL, USA, 2021. [Google Scholar]
- Jin, H.Y.; Park, T.S. Role of inflammatory biomarkers in diabetic peripheral neuropathy. J. Diabetes Investig. 2018, 9, 1016–1018. [Google Scholar] [CrossRef]
- Zafeiri, M.; Tsioutis, C.; Kleinaki, Z.; Manolopoulos, P.; Ioannidis, I.; Dimitriadis, G. Clinical characteristics of patients with co-existent diabetic peripheral neuropathy and depression: A systematic review. Exp. Clin. Endocrinol. Diabetes Off. J. Ger. Soc. Endocrinol. Ger. Diabetes Assoc. 2021, 129, 77–85. [Google Scholar] [CrossRef]
- Sloan, G.; Shillo, P.; Selvarajah, D.; Wu, J.; Wilkinson, I.D.; Tracey, I.; Anand, P.; Tesfaye, S. A new look at painful diabetic neuropathy. Diabetes Res. Clin. Pract. 2018, 144, 177–191. [Google Scholar] [CrossRef]
- Cole, J.B.; Florez, J.C. Genetics of diabetes mellitus and diabetes complications. Nat. Rev. Nephrol. 2020, 16, 377–390. [Google Scholar] [CrossRef]
- Braffett, B.H.; Gubitosi-Klug, R.A.; Albers, J.W.; Feldman, E.L.; Martin, C.L.; White, N.H.; Orchard, T.J.; Lopes-Virella, M.; Lachin, J.M.; Pop-Busui, R. Risk factors for diabetic peripheral neuropathy and cardiovascular autonomic neuropathy in the diabetes control and complications trial/epidemiology of diabetes interventions and complications (dcct/edic) study. Diabetes 2020, 69, 1000–1010. [Google Scholar] [CrossRef] [PubMed]
- Liu, X.; Xu, Y.; An, M.; Zeng, Q. The risk factors for diabetic peripheral neuropathy: A meta-analysis. PLoS ONE 2019, 14, e0212574. [Google Scholar] [CrossRef] [PubMed]
- Seyedizadeh, S.H.; Cheragh-Birjandi, S.; Hamedi Nia, M.R. The effects of combined exercise training (resistance-aerobic) on serum kinesin and physical function in type 2 diabetes patients with diabetic peripheral neuropathy (randomized controlled trials). J. Diabetes Res. 2020, 2020, 6978128. [Google Scholar] [CrossRef] [PubMed]
- Zilliox, L.A.; Russell, J.W. Physical activity and dietary interventions in diabetic neuropathy: A systematic review. Clin. Auton. Res. Off. J. Clin. Auton. Res. Soc. 2019, 29, 443–455. [Google Scholar] [CrossRef]
- Rumora, A.E.; Savelieff, M.G.; Sakowski, S.A.; Feldman, E.L. Disorders of mitochondrial dynamics in peripheral neuropathy: Clues from hereditary neuropathy and diabetes. Int. Rev. Neurobiol. 2019, 145, 127–176. [Google Scholar] [PubMed]
- Spallone, V.; Ciccacci, C.; Latini, A.; Borgiani, P. What is in the field for genetics and epigenetics of diabetic neuropathy: The role of micrornas. J. Diabetes Res. 2021, 2021, 5593608. [Google Scholar] [CrossRef]
- Cheng, Y.; Liu, J.; Luan, Y.; Liu, Z.; Lai, H.; Zhong, W.; Yang, Y.; Yu, H.; Feng, N.; Wang, H.; et al. Sarm1 gene deficiency attenuates diabetic peripheral neuropathy in mice. Diabetes 2019, 68, 2120–2130. [Google Scholar] [CrossRef]
- Shillo, P.; Selvarajah, D.; Greig, M.; Gandhi, R.; Rao, G.; Wilkinson, I.D.; Anand, P.; Tesfaye, S. Reduced vitamin d levels in painful diabetic peripheral neuropathy. Diabet. Med. A J. Br. Diabet. Assoc. 2019, 36, 44–51. [Google Scholar] [CrossRef]
- Xue, T.; Zhang, X.; Xing, Y.; Liu, S.; Zhang, L.; Wang, X.; Yu, M. Advances about immunoinflammatory pathogenesis and treatment in diabetic peripheral neuropathy. Front. Pharmacol. 2021, 12, 748193. [Google Scholar] [CrossRef]
- Freedland, S.J.; Aronson, W.J. Words of wisdom. Re: Weight loss with a low-carbohydrate, mediterranean, or low-fat diet. N. Engl. J. Med. 2008, 359, 229–241. Eur. Urol. 2009, 55, 249–250. [Google Scholar] [CrossRef]
- Larsen, R.N.; Mann, N.J.; Maclean, E.; Shaw, J.E. The effect of high-protein, low-carbohydrate diets in the treatment of type 2 diabetes: A 12 month randomised controlled trial. Diabetologia 2011, 54, 731–740. [Google Scholar] [CrossRef] [PubMed]
- Yumuk, V.; Tsigos, C.; Fried, M.; Schindler, K.; Busetto, L.; Micic, D.; Toplak, H.; Obesity Management Task Force of the European Association for the Study of Obesity. European guidelines for obesity management in adults. Obes. Facts 2015, 8, 402–424. [Google Scholar] [CrossRef] [PubMed]
- Wadden, T.A.; West, D.S.; Neiberg, R.H.; Wing, R.R.; Ryan, D.H.; Johnson, K.C.; Foreyt, J.P.; Hill, J.O.; Trence, D.L.; Vitolins, M.Z.; et al. One-year weight losses in the look ahead study: Factors associated with success. Obesity 2009, 17, 713–722. [Google Scholar] [CrossRef] [PubMed]
- Leitner, D.R.; Fruhbeck, G.; Yumuk, V.; Schindler, K.; Micic, D.; Woodward, E.; Toplak, H. Obesity and type 2 diabetes: Two diseases with a need for combined treatment strategies - easo can lead the way. Obes. Facts 2017, 10, 483–492. [Google Scholar] [CrossRef]
- Geliebter, A.; Ochner, C.N.; Dambkowski, C.L.; Hashim, S.A. Obesity-related hormones and metabolic risk factors: A randomized trial of diet plus either strength or aerobic training versus diet alone in overweight participants. J. Diabetes Obes. 2014, 1, 1–7. [Google Scholar]
- Willis, L.H.; Slentz, C.A.; Bateman, L.A.; Shields, A.T.; Piner, L.W.; Bales, C.W.; Houmard, J.A.; Kraus, W.E. Effects of aerobic and/or resistance training on body mass and fat mass in overweight or obese adults. J. Appl. Physiol. 2012, 113, 1831–1837. [Google Scholar] [CrossRef]
- Thibault, R.; Huber, O.; Azagury, D.E.; Pichard, C. Twelve key nutritional issues in bariatric surgery. Clin. Nutr. 2016, 35, 12–17. [Google Scholar] [CrossRef]
- Jackson, V.M.; Breen, D.M.; Fortin, J.P.; Liou, A.; Kuzmiski, J.B.; Loomis, A.K.; Rives, M.L.; Shah, B.; Carpino, P.A. Latest approaches for the treatment of obesity. Expert Opin. Drug Discov. 2015, 10, 825–839. [Google Scholar] [CrossRef]
- Wang, Z.; Xiong, H.; Ren, T.Y.S. Repair of damaged pancreatic beta cells: New hope for a type 2 diabetes reversal? J Transl Int Med 2021, 9, 150–151. [Google Scholar] [CrossRef]
- Tak, Y.J.; Lee, S.Y. Long-term efficacy and safety of anti-obesity treatment: Where do we stand? Curr. Obes. Rep. 2021, 10, 14–30. [Google Scholar] [CrossRef]
- Khera, R.; Murad, M.H.; Chandar, A.K.; Dulai, P.S.; Wang, Z.; Prokop, L.J.; Loomba, R.; Camilleri, M.; Singh, S. Association of pharmacological treatments for obesity with weight loss and adverse events: A systematic review and meta-analysis. JAMA 2016, 315, 2424–2434. [Google Scholar] [CrossRef] [PubMed]
- Davies, M.J.; Bergenstal, R.; Bode, B.; Kushner, R.F.; Lewin, A.; Skjoth, T.V.; Andreasen, A.H.; Jensen, C.B.; DeFronzo, R.A.; Group, N.N.S. Efficacy of liraglutide for weight loss among patients with type 2 diabetes: The scale diabetes randomized clinical trial. JAMA 2015, 314, 687–699. [Google Scholar] [CrossRef] [PubMed]
- Yanovski, S.Z.; Yanovski, J.A. Long-term drug treatment for obesity: A systematic and clinical review. JAMA 2014, 311, 74–86. [Google Scholar] [CrossRef]
- Daubresse, M.; Alexander, G.C. The uphill battle facing antiobesity drugs. Int. J. Obes. 2015, 39, 377–378. [Google Scholar] [CrossRef]
- Fried, M.; Yumuk, V.; Oppert, J.M.; Scopinaro, N.; Torres, A.J.; Weiner, R.; Yashkov, Y.; Fruhbeck, G.; European Association for the Study of Obesity; International Federation for the Surgery of Obesity-European Chapter. Interdisciplinary european guidelines on metabolic and bariatric surgery. Obes. Facts 2013, 6, 449–468. [Google Scholar] [CrossRef] [PubMed]
- Jabbour, G.; Salman, A. Bariatric surgery in adults with obesity: The impact on performance, metabolism, and health indices. Obes. Surg. 2021, 31, 1767–1789. [Google Scholar] [CrossRef]
- Esteghamati, A.; Mazaheri, T.; Vahidi Rad, M.; Noshad, S. Complementary and alternative medicine for the treatment of obesity: A critical review. Int. J. Endocrinol. Metab. 2015, 13, e19678. [Google Scholar] [CrossRef]
- Liu, Y.; Sun, M.; Yao, H.; Liu, Y.; Gao, R. Herbal medicine for the treatment of obesity: An overview of scientific evidence from 2007 to 2017. Evid. Based Complement. Alternat. Med. 2017, 2017, 8943059. [Google Scholar] [CrossRef]
- Zhou, Q.; Chang, B.; Chen, X.Y.; Zhou, S.P.; Zhen, Z.; Zhang, L.L.; Sun, X.; Zhou, Y.; Xie, W.Q.; Liu, H.F.; et al. Chinese herbal medicine for obesity: A randomized, double-blinded, multicenter, prospective trial. Am. J. Chin. Med. 2014, 42, 1345–1356. [Google Scholar] [CrossRef]
- Gao, Y.; Wang, Y.; Zhou, J.; Hu, Z.; Shi, Y. Effectiveness of electroacupuncture for simple obesity: A systematic review and meta-analysis of randomized controlled trials. Evid. Based Complement. Alternat. Med. 2020, 2020, 2367610. [Google Scholar] [CrossRef]
- Darbandi, M.; Darbandi, S.; Owji, A.A.; Mokarram, P.; Mobarhan, M.G.; Fardaei, M.; Zhao, B.; Abdi, H.; Nematy, M.; Safarian, M.; et al. Auricular or body acupuncture: Which one is more effective in reducing abdominal fat mass in iranian men with obesity: A randomized clinical trial. J. Diabetes Metab. Disord. 2014, 13, 92. [Google Scholar] [CrossRef] [PubMed]
- Wang, D.; Rong, P.J.; Li, S.Y.; Wang, Y.F.; Zhang, Z.X.; He, J.K. [bibliometric analysis on clinical trials of auricular acupuncture treatment of obesity]. Zhen Ci Yan Jiu 2020, 45, 334–338. [Google Scholar] [PubMed]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Lu, X.; Jin, Y.; Li, D.; Zhang, J.; Han, J.; Li, Y. Multidisciplinary Progress in Obesity Research. Genes 2022, 13, 1772. https://doi.org/10.3390/genes13101772
Lu X, Jin Y, Li D, Zhang J, Han J, Li Y. Multidisciplinary Progress in Obesity Research. Genes. 2022; 13(10):1772. https://doi.org/10.3390/genes13101772
Chicago/Turabian StyleLu, Xiaoqing, Yuxin Jin, Dexin Li, Jingxin Zhang, Jingyan Han, and Yin Li. 2022. "Multidisciplinary Progress in Obesity Research" Genes 13, no. 10: 1772. https://doi.org/10.3390/genes13101772
APA StyleLu, X., Jin, Y., Li, D., Zhang, J., Han, J., & Li, Y. (2022). Multidisciplinary Progress in Obesity Research. Genes, 13(10), 1772. https://doi.org/10.3390/genes13101772